Ipratropium Bromide Solution
Product Images NDC 76204-100

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide (NDC 76204-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ritedose Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rpsc0269 Rdp 0.02 25 Ct Brick Carton

This product is an Ipratropium Bromide Inhalation Solution for oral inhalation only, available in 25 x 2.5 mL sterile unit-dose vials. The NDC number is 76204-100-25 with a concentration of 0.5 mg / 2.5 mL. The product is manufactured by The Ritedosa Corporation, Columbia, SC 29203, for Ritacose Pharmaceuticals, LLC. The product is only for prescription use. The rest of the text does not appear to provide useful information.*

FDA Label Image

Rpsc0270 Rdp 0.02 30 Ct Brick Carton

Ipratropium Bromide Inhalation Solution, 0.02% is a medication that is intended to be taken orally via inhalation. This drug is manufactured by a company located at 30226 Mt. St. Utica, MI. The text has various characters, letters, and numbers arranged in no specific order or pattern, which makes it difficult to read and understand the meaning behind it.*

FDA Label Image

Rpsc0271 Rdp 0.02 60 Ct Brick Carton

This text seems to be related to a medication called "Ipratropium Bromide Inhalation Solution, 0.02%". The solution is meant for oral inhalation and contains 0.5mg/2.5mL. The rest of the text does not provide any additional useful information and appears to be a mix of random characters and symbols.*

FDA Label Image

Rpsc0300 Rdp 0.02 30 Ct Singles Carton

The text contains information about a medication identified as NDC 76204-100-01, called Ipratropium Bromide, which is an inhalation solution that must be taken orally by patients. The solution has 0.02% Ipratropium Bromide, and each 25mL vial contains 05mg of this medication. It is manufactured by The Ritedose Corporation and comes in a foil pouch with 30 sterile unit-dose vials of 2.5mL each. The rest of the text is not useful as it seems to contain errors making it unreadable.*

FDA Label Image

Chemical Structure (Ipratropium 01)

FDA Label Image

Figure 1 (Ipratropium 02)

FDA Label Image

Figure 2 (Ipratropium 03)

Not available. The text is incomplete and does not provide enough information to generate a useful description.*

FDA Label Image

Figure 3 (Ipratropium 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.